321 related articles for article (PubMed ID: 37818196)
1. The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies.
Xi Y; Gao L; Li S; Sun K; Chen P; Cai Z; Ren W; Zhi K
Front Pharmacol; 2023; 14():1228985. PubMed ID: 37818196
[TBL] [Abstract][Full Text] [Related]
2. Cell death in head and neck cancer pathogenesis and treatment.
Raudenská M; Balvan J; Masařík M
Cell Death Dis; 2021 Feb; 12(2):192. PubMed ID: 33602906
[TBL] [Abstract][Full Text] [Related]
3. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
4. Regulated cell death (RCD) in cancer: key pathways and targeted therapies.
Peng F; Liao M; Qin R; Zhu S; Peng C; Fu L; Chen Y; Han B
Signal Transduct Target Ther; 2022 Aug; 7(1):286. PubMed ID: 35963853
[TBL] [Abstract][Full Text] [Related]
5. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma.
Xue Y; Jiang X; Wang J; Zong Y; Yuan Z; Miao S; Mao X
Biomark Res; 2023 Jan; 11(1):2. PubMed ID: 36600313
[TBL] [Abstract][Full Text] [Related]
6. Paeoniflorigenone regulates apoptosis, autophagy, and necroptosis to induce anti-cancer bioactivities in human head and neck squamous cell carcinomas.
Park KR; Lee H; Kim SH; Yun HM
J Ethnopharmacol; 2022 Apr; 288():115000. PubMed ID: 35051602
[TBL] [Abstract][Full Text] [Related]
7. Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review.
Siquara da Rocha LO; de Morais EF; de Oliveira LQR; Barbosa AV; Lambert DW; Gurgel Rocha CA; Coletta RD
Biology (Basel); 2024 Feb; 13(2):. PubMed ID: 38392321
[TBL] [Abstract][Full Text] [Related]
8. Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review).
Yang M; Guo R; Chen X; Song G; Zhang F
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37052257
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
10. Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model.
Li J; Huang S; Zeng L; Li K; Yang L; Gao S; Guan C; Zhang S; Lao X; Liao G; Liang Y
Cell Death Dis; 2020 May; 11(5):391. PubMed ID: 32444644
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the interplay between m6A modification and programmed cell death in cancer.
Chen J; Ye M; Bai J; Hu C; Lu F; Gu D; Yu P; Tang Q
Int J Biol Sci; 2023; 19(6):1748-1763. PubMed ID: 37063421
[TBL] [Abstract][Full Text] [Related]
12. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
13. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
Zhou P; Zhang S; Wang M; Zhou J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
[TBL] [Abstract][Full Text] [Related]
14. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
[TBL] [Abstract][Full Text] [Related]
15. Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy.
Scimeca M; Rovella V; Palumbo V; Scioli MP; Bonfiglio R; Tor Centre ; Melino G; Piacentini M; Frati L; Agostini M; Candi E; Mauriello A
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509299
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs.
Zhang Q; Fan X; Zhang X; Ju S
J Transl Med; 2023 Jul; 21(1):514. PubMed ID: 37516888
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment.
Yang J; Gu Z
Front Pharmacol; 2024; 15():1283465. PubMed ID: 38313306
[TBL] [Abstract][Full Text] [Related]
18. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
Li Z; Shen L; Li Y; Shen L; Li N
Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death in tumor immunity: mechanistic insights and clinical implications.
Wang M; Yu F; Zhang Y; Li P
Front Immunol; 2023; 14():1309635. PubMed ID: 38283351
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
